Dr. D’Amico discusses his first clinical trial, RT+/- 6 mo ADT in unfavorable-risk prostate cancer (JAMA 2008). Such a great story of perseverance, ingenuity, & making the most of a situation.
Dr. D’Amico discusses his first clinical trial, RT+/- 6 mo ADT in unfavorable-risk prostate cancer (JAMA 2008). Such a great story of perseverance, ingenuity, & making the most of a situation.